1. Home
  2. SLNO

as 07-22-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

Founded: N/A Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 1.5B IPO Year: 2014
Target Price: $60.33 AVG Volume (30 days): 550.1K
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.06 EPS Growth: N/A
52 Week Low/High: $3.69 - $53.82 Next Earning Date: 08-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

SLNO Daily Stock ML Predictions

Stock Insider Trading Activity of Soleno Therapeutics Inc. (SLNO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Anish Bhatnagar SLNO CHIEF EXECUTIVE OFFICER Jul 1 '24 Sell $41.63 15,058 $626,795.27 133,534 SEC Form 4
Anish Bhatnagar SLNO CHIEF EXECUTIVE OFFICER Jul 1 '24 Sell $41.22 4,198 $173,048.70 148,592 SEC Form 4
Hirano Patricia C SLNO SEE REMARKS Jul 1 '24 Sell $41.63 1,697 $70,638.30 48,754 SEC Form 4
Hirano Patricia C SLNO SEE REMARKS Jul 1 '24 Sell $41.22 473 $19,497.86 50,451 SEC Form 4
Yen Kristen SLNO SEE REMARKS Jul 1 '24 Sell $41.63 1,697 $70,638.30 21,252 SEC Form 4
Yen Kristen SLNO SEE REMARKS Jul 1 '24 Sell $41.22 473 $19,497.86 22,949 SEC Form 4
Vivo Opportunity, LLC SLNO 10% Owner Apr 29 '24 Sell $47.80 750,000 $35,850,000.00 7,668,093 SEC Form 4
Vivo Opportunity, LLC SLNO 10% Owner Apr 29 '24 Sell $45.13 351,242 $15,851,551.46 7,316,851 SEC Form 4
Anish Bhatnagar SLNO CHIEF EXECUTIVE OFFICER Apr 1 '24 Sell $41.67 7,597 $316,544.96 152,790 SEC Form 4
Anish Bhatnagar SLNO CHIEF EXECUTIVE OFFICER Apr 1 '24 Sell $41.12 11,383 $468,099.69 160,387 SEC Form 4
Yen Kristen SLNO SEE REMARKS Apr 1 '24 Sell $41.12 1,330 $54,693.19 24,310 SEC Form 4
Yen Kristen SLNO SEE REMARKS Apr 1 '24 Sell $41.67 888 $37,000.38 23,422 SEC Form 4
Hirano Patricia C SLNO SEE REMARKS Apr 1 '24 Sell $41.12 1,330 $54,693.19 41,812 SEC Form 4
Hirano Patricia C SLNO SEE REMARKS Apr 1 '24 Sell $41.67 888 $37,000.38 50,924 SEC Form 4
Mackaness James H SLNO CHIEF FINANCIAL OFFICER Apr 1 '24 Sell $41.12 3,104 $127,644.86 65,024 SEC Form 4
Mackaness James H SLNO CHIEF FINANCIAL OFFICER Apr 1 '24 Sell $41.67 2,071 $86,292.56 62,953 SEC Form 4
Hirano Patricia C SLNO SEE REMARKS Jan 25 '24 Sell $48.30 832 $40,185.60 43,142 SEC Form 4
Anish Bhatnagar SLNO CHIEF EXECUTIVE OFFICER Jan 25 '24 Sell $48.30 2,527 $122,054.10 171,770 SEC Form 4
Yen Kristen SLNO SEE REMARKS Jan 25 '24 Sell $48.30 397 $19,175.10 25,640 SEC Form 4
Yen Kristen SLNO See Remarks Dec 12 '23 Sell $36.64 3,629 $132,967.29 18,321 SEC Form 4
Yen Kristen SLNO See Remarks Dec 12 '23 Sell $37.02 16,284 $602,906.96 2,037 SEC Form 4
Yen Kristen SLNO See Remarks Dec 12 '23 Sell $37.76 17,916 $676,556.53 2,037 SEC Form 4
Anish Bhatnagar SLNO Chief Executive Officer Dec 11 '23 Sell $35.26 51,205 $1,805,478.06 66,500 SEC Form 4
Anish Bhatnagar SLNO Chief Executive Officer Dec 11 '23 Sell $36.00 35,272 $1,269,728.51 31,228 SEC Form 4
Anish Bhatnagar SLNO Chief Executive Officer Dec 11 '23 Sell $37.01 6,931 $256,494.82 24,297 SEC Form 4

Share on Social Networks: